In particular, the novel GHRH antagonists of the Miami (MIA) series, MIA-690 and MIA-602, were found to inhibit growth of different human cancer lines and xenografted into nude mice in microgram doses after subcutaneous administration15,17,18. This evidence concerns the gene GHRH and cancer.